SEIZMET TRIO 0.2 Mg : View Uses, Dosage, Side Effects.

SEIZMET TRIO 0.2 Mg

Glimepiride (2mg), Metformin SR (500mg), Voglibose (0.2mg)

SEIZMET TRIO 0.2 is a multifaceted oral medication specifically formulated for the management of type 2 diabetes. This combination of Glimepiride, Metformin Sustained Release (SR), and Voglibose offers a triple mechanism of action to improve blood sugar control, thereby reducing the risk of diabetes-related complications. This guide covers detailed information about the uses, dosage, price, side effects, and composition of SEIZMET TRIO 0.2.

Uses

SEIZMET TRIO 0.2 is used to:

• Control Blood Sugar Levels: Effectively manages high blood sugar in individuals with type 2 diabetes, helping to prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.
• Reduce Risk of Diabetes-Related Complications: Helps decrease the risk of cardiovascular events, which are common in diabetic patients.

Dosage and Administration

• Standard Dosage: The typical starting dose for SEIZMET TRIO 0.2 depends on the patient's current treatment regimen, effectiveness, and tolerability. It is usually taken once daily with the first main meal of the day.
• Method of Administration: The tablet should be swallowed whole, not crushed or chewed, to maintain the efficacy of the sustained-release formulation of Metformin.
• Dosage Adjustments: Dosage may be adjusted based on the patient's blood glucose levels and overall response to the medication, under the supervision of a healthcare provider.

Price

The price of SEIZMET TRIO 0.2 can vary based on factors such as the pharmacy, geographic location, and insurance coverage. It is generally considered cost-effective for the management of type 2 diabetes, given its comprehensive approach to controlling blood sugar levels.

Side Effects

While SEIZMET TRIO 0.2 is generally well-tolerated, some patients may experience side effects, including:

• Common Side Effects: Hypoglycemia (especially with Glimepiride), gastrointestinal disturbances (primarily from Metformin), and flatulence and bloating (from Voglibose).
• Serious Side Effects: Lactic acidosis (a rare but serious condition associated with Metformin), severe hypoglycemia, and liver function abnormalities. These require immediate medical attention.

Composition

Each tablet of SEIZMET TRIO 0.2 contains:

• Active Ingredients: Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.2mg).
• Inactive Ingredients: May include excipients like cellulose, starch, and magnesium stearate, which facilitate the drug’s release and absorption.

Conclusion

SEIZMET TRIO 0.2 offers an effective and efficient approach to managing type 2 diabetes through its combination of three different anti-diabetic agents, each targeting different aspects of diabetes control. This medication can significantly improve the quality of life for patients by maintaining stable blood sugar levels and reducing the risk of complications. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. Gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW